World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
18932
World Ranking
19174
National Ranking
1730

Eliot H. Ohlstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eliot H. Ohlstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 229 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eliot H. Ohlstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eliot H. Ohlstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eliot H. Ohlstein is affiliated with GlaxoSmithKline in the United Kingdom and has contributed extensively to the field of medicine, with a particular focus on cardiology, cardiovascular medicine, surgery, pharmacology, pulmonary and respiratory medicine, and molecular biology. Their research spans a variety of topics related to cardiovascular health, pulmonary diseases, and molecular mechanisms involved in tissue remodeling and fibrosis.

The scientist has published work in several notable venues, including:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • British Journal of Pharmacology
  • Pharmacological Reviews

Key areas of study for Eliot H. Ohlstein include:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pharmacology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Their research covers main topics such as:

  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Apelin-related biomedical research
  • Cardiovascular Disease and Adiposity
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cardiac Fibrosis and Remodeling
  • Tissue Engineering and Regenerative Medicine
  • S100 Proteins and Annexins

Frequently collaborating with other researchers, Eliot H. Ohlstein has worked extensively alongside Anthony P. Davenport, Stephen A. Douglas, Alain Fournier, Adel Giaid, and Henry Krum. These collaborations have yielded multiple publications and contributed to a wider understanding of pharmacology and cardiovascular diseases.

Recent significant publications include:

  • International Union of Basic and Clinical Pharmacology. CXVI: NC-IUPHAR and Pharmacological Reviews: 30+ Years of Collaboration-Editorial, 2024, Pharmacological Reviews
  • Therapeutic targets of fibrosis: Translational advances and current challenges, 2023, British Journal of Pharmacology
  • Endothelin receptors in GtoPdb v.2023.1, 2023, IUPHAR/BPS Guide to Pharmacology CITE
  • Urotensin receptor in GtoPdb v.2023.1, 2023, IUPHAR/BPS Guide to Pharmacology CITE
  • Urotensin receptor in GtoPdb v.2021.3, 2021, IUPHAR/BPS Guide to Pharmacology CITE

Best Publications

  • Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

    Robert S. Ames;Henry M. Sarau;Johathan K. Chambers;Robert N. Willette

  • Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in Rats: Inhibition of Matrix Metalloproteinase-9 Reduces Infarct Size

    Anne M. Romanic;Raymond F. White;Anthony J. Arleth;Eliot H. Ohlstein

  • Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators

    BT Mellion;LJ Ignarro;EH Ohlstein;EG Pontecorvo

  • Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation

    Feng Gao;Erhe Gao;Tian-Li Yue;Eliot H. Ohlstein

  • Chemokine Receptors in Human Endothelial Cells: FUNCTIONAL EXPRESSION OF CXCR4 AND ITS TRANSCRIPTIONAL REGULATION BY INFLAMMATORY CYTOKINES *

    Shalley K. Gupta;Paul G. Lysko;Kodandaram Pillarisetti;Eliot Ohlstein

  • In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

    Tian-li Yue;Jun Chen;Weike Bao;Padma K. Narayanan

  • Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia.

    Frank C. Barone;Robert K. Clark;William J. Price;Raymond F. White

  • Congestive heart failure and expression of myocardial urotensin II

    Stephen A Douglas;Lara Tayara;Eliot H Ohlstein;Nadine Halawa

  • Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.

    F.C. Barone;E.A. Irving;A.M. Ray;J.C. Lee

  • Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

    Stephen A Douglas;Anthony C Sulpizio;Valerie Piercy;Henry M Sarau

  • SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia

    F C Barone;E A Irving;A M Ray;J C Lee

  • Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

    Stephen A. Douglas;Eliot H. Ohlstein

  • IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels

    Anthony J. Harmar;Rebecca A. Hills;Edward M. Rosser;Martin Jones

  • Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat.

    M R MacLean;D Alexander;A Stirrat;M Gallagher

  • Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

    Alison Stirrat;Marie Gallagher;Stephen A. Douglas;Eliot H. Ohlstein

  • Endothelin levels increase in rat focal and global ischemia

    F. C. Barone;M. Y.-T. Globus;W. J. Price;R. F. White

  • Activation of Peroxisome Proliferator-Activated Receptor-α Protects the Heart From Ischemia/Reperfusion Injury

    Tian-li Yue;Weike Bao;Beat M. Jucker;Juan-li Gu

  • EXTRACELLULAR SIGNAL-REGULATED KINASE PLAYS AN ESSENTIAL ROLE IN HYPERTROPHIC AGONISTS, ENDOTHELIN-1 AND PHENYLEPHRINE-INDUCED CARDIOMYOCYTE HYPERTROPHY

    Tian-Li Yue;Juan-Li Gu;Chuanlin Wang;Alastair D. Reith

  • Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.

    B T Mellion;L J Ignarro;C B Myers;E H Ohlstein

  • SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist

    E H Ohlstein;P Nambi;S A Douglas;R M Edwards

Frequent Co-Authors

Giora Z. Feuerstein
Giora Z. Feuerstein Debina Diagnostics
Ponnal Nambi
Ponnal Nambi Pfizer (United States)
Anthony P. Davenport
Anthony P. Davenport University of Cambridge
Louis J. Ignarro
Louis J. Ignarro University of California, Los Angeles
Henry M. Sarau
Henry M. Sarau GlaxoSmithKline (United Kingdom)
John C. Lee
John C. Lee The University of Texas Health Science Center at San Antonio
Raymond Baker
Raymond Baker MSD (United States)
Richard R. Neubig
Richard R. Neubig Michigan State University
William A. Catterall
William A. Catterall University of Washington
Anthony J. Harmar
Anthony J. Harmar University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one of many pathways in the healthcare field. If you’re exploring alternatives, several online degrees offer promising careers with flexible entry points. For those interested in direct patient care but seeking a faster or less test-intensive route, there are nursing schools that don't require teas or hesi, making it easier to start your nursing journey.

If you are drawn toward the organizational or management side of healthcare, pursuing a healthcare administration degree online can open doors to roles in hospital administration, healthcare policy, or operations. Nurses looking to advance their careers might consider rn to fnp bridge programs, which provide a path to becoming a Family Nurse Practitioner without starting over.

Nutrition is another crucial aspect of healthcare, and earning an online bs in nutrition equips you for careers in dietetics, wellness coaching, or public health. Each pathway meets different interests and lifestyle needs, giving you many options to impact the health sector beyond medical school.

Best Scientists Citing Eliot H. Ohlstein

Trending Scientists

Recently Published Articles